Vanderbilt University Medical Center

SEP 9, 2026 · INTERVENTIONAL STUDY

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit

ClinicalTrials.gov

This is a planned interventional mechanistic study with no results reported; it aims to characterize glucose metabolism in immune cells during critical illness using isotope tracing in a small ICU cohort.

SEP 9, 2026 · PHASE 3 TRIAL

REVERSE-Long COVID-19 With Baricitinib Study

ClinicalTrials.gov

This is a withdrawn Phase 3 trial registration with no results posted; the study was not completed and therefore provides no evidence of efficacy or safety.

AUG 20, 2026 · PHASE 1 TRIAL

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

ClinicalTrials.gov

This is an early-phase, uncontrolled pharmacokinetic study in a small pediatric population designed to characterize drug dosing rather than efficacy, with no results yet reported.

AUG 18, 2026 · INTERVENTIONAL STUDY

Transition to Ambulatory Bariatric Surgery (TABS) Trial

ClinicalTrials.gov

This is a planned interventional trial with no results posted; it addresses a pragmatic outcome (ED visits post-bariatric surgery) but remains in the registration phase with recruitment not yet begun.

AUG 14, 2026 · OBSERVATIONAL STUDY

Vanderbilt Memory and Aging Project

ClinicalTrials.gov

This is a registry record for an ongoing observational cohort study with no reported results; it describes planned enrollment and outcome measures only.

AUG 12, 2026 · INTERVENTIONAL STUDY

Metabolic Flux Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease

ClinicalTrials.gov

This is a planned pilot study with no results posted; it aims to characterize metabolic flux changes after bariatric surgery in MASLD but carries inherent limitations of small sample size and single-center design.

AUG 12, 2026 · PHASE 2 TRIAL

HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no results posted; the study is not yet recruiting and represents early-phase evaluation of a dietary supplement intervention in a specific population.

AUG 11, 2026 · PHASE 4 TRIAL

Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2

ClinicalTrials.gov

This is a completed mechanistic Phase 4 crossover study testing a hypothesis about bradykinin's role in ARB/NEP inhibitor hypotension in heart failure; no results are reported in this registry record.